+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT



Detection of recurrent colorectal carcinoma with In-111 CYT-103 scintigraphy in a patient with nondiagnostic MRI and CT



Clinical Nuclear Medicine 19(11): 1004-1007



Detection of recurrent colorectal carcinoma can be a diagnostic challenge. The authors report a case of a patient who, after resection of his primary colorectal carcinoma, had a recurrence that was not detected by MRI or serial CT examination, but was clearly demonstrated by In-111 labeled CYT-103 scintigraphy. This case demonstrates the use of CYT-103 scintigraphy in detecting recurrent colorectal cancer in a patient, despite results of nondiagnostic MRI or serial CT examinations.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008441547

Download citation: RISBibTeXText

PMID: 7842571

DOI: 10.1097/00003072-199411000-00016


Related references

Immune scintigraphy Promising role in detection of recurrent and metastatic colorectal cancer. Investigative Radiology 27(12): 1121, 1992

Scintigraphic evaluation of a patient with lung cavitations. Ga-67 scintigraphy is nondiagnostic. Clinical Nuclear Medicine 19(11): 1012-1014, 1994

Serial CEA assays and liver scintigraphy for the detection of hepatic metastases from colorectal carcinoma. Diseases of the Colon and Rectum 25(3): 191-197, 1982

Comparative study of ultrasonography and scintigraphy in liver metastases detection in cases of colorectal carcinoma. Journal de Radiologie 63(2): 97-100, 1982

Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy. Hepato-Gastroenterology 47(32): 405-413, 2000

Detection of recurrent colorectal carcinoma with whole-body FDG PET. Journal of Nuclear Medicine 37(5 SUPPL ): 261P, 1996

Recurrent colorectal carcinoma: detection, treatment, and other considerations. Surgery 69(1): 9-23, 1971

CEA assays in postoperative detection of recurrent colorectal carcinoma. Nihon Gan Chiryo Gakkai Shi 15(7): 1137-1142, 1980

Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery 130(4): 636-43; Discussion 643-4, 2001

Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma. Nuclear Medicine Communications 36(3): 242-250, 2015

Detection of recurrent colorectal carcinoma with F-18-FDG positron emission tomography. Journal of Nuclear Medicine 36(5 SUPPL ): 107P, 1995

Detection of recurrent colorectal carcinoma with CDET-FDG Three years experience. Journal of Nuclear Medicine 42(5 Supplement): 124P, 2001

Value of a routine follow-up endoscopy program for the detection of recurrent colorectal carcinoma. American Journal of Gastroenterology 83(12): 1355-1360, 1988

Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET. Nuclear Medicine Communications 25(2): 105-113, 2004

Recurrent colorectal carcinoma detection with repeated infusions of indium 111 zce 025 moab. Journal of Nuclear Medicine 30(5 SUPPL): 748-749, 1989